FDA Documents of Cangene BioPharma, LLC dba Emergent BioSolutions
Cangene BioPharma, LLC dba Emergent BioSolutions is an organization that has been audited by the FDA 5 times between 2015 and 2022 across all 2 sites.
Documents
FDA 483 Cangene BioPharma, Baltimore | February 2022
Available Now - $199
Issued on: Feb 18, 2022
Human Drug Form 483
FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Rockville | 2019
Out-of-stock
Issued on: Feb 16, 2019
Biologic Form 483
FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Baltimore | 2017
Out-of-stock
Issued on: Jan 27, 2017
Human Drug Form 483
FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Baltimore | 2016
Out-of-stock
Issued on: Dec 20, 2016
Human Drug Form 483
FDA 483 Cangene BioPharma, LLC dba Emergent BioSolutions, Baltimore | 2015
Out-of-stock
Issued on: Aug 28, 2015
Human Drug Form 483
FDA Investigators(9)
- Sena G. Dissmeyer, FDA Investigator
- Robert J. Martin, FDA Investigator
- Debra M. Emerson, FDA Investigator
- Marion Michaelis, FDA Investigator
- Ephrem T. Hunde, FDA Investigator
- Jessica Hankins, FDA Investigator
- Steven P. Donald, FDA Investigator
- Pratik S. Upadhyay, FDA Investigator
- Toyin B. Oladimeji, FDA Investigator